Axogen, Inc. — Director's Dealing 2021

Jun 3, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Axogen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2021-06-01

Reporting Person: Blackford Quentin S. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-06-01	Common Stock	M	6173	—	Acquired	24299	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-01	Restricted Stock Units	$	M	6173	Disposed		Common Stock (6173.0)	Direct
2021-06-01	Stock Option (right to purchase)	$19.76	A	6030	Acquired	2031-06-01	Common Stock (6030.0)	Direct
2021-06-01	Restricted Stock Units	$	A	3036	Acquired		Common Stock (3036.0)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.

F2: This reflects the number of restricted stock units that became vested as of June 1, 2021.

F3: Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2022, one year from the anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units.